Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients In North America, the number of new cases of prostate cancer increases every year. Many efforts have been made to develop more efficient and safer curative treatments for high risk prostat...

• Country None
• organs None
• Specialty None

Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate To evaluate the efficacy of LHRH agonist with adjuvant pelvic radiation therapy in post radical prostatectomy patients with high risk pathological features for failure. To determine the fr...

• Country None
• organs None
• Specialty None

Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis One of the biggest problems facing prostate cancer patients and their treating physicians is who needs to be treated and when. Common clinical and pathological parameters are useful (PSA, ...

• Country None
• organs None
• Specialty None

Management of Castration-Resistant Prostate Cancer With Oligometastases This adaptive phase II/III randomized trial is designed to demonstrate that eradication of oligometastases by SBRT is a promising and emerging way to delay disease progression and postpone...

• Country None
• organs None
• Specialty None

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy Approximately 50%-95% of prostate cancer patients undergoing radiation therapy (RT) develop symptomatic urinary problems .These symptoms can significantly diminish a patient's quality of l...

• Country None
• organs None
• Specialty None

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate In North America, around a quarter a million men are diagnosed with prostate cancer every year, and about 31,000 patients will die of their disease each year. Like other western countries,...

• Country None
• organs None
• Specialty None